We encourage you to republish this article online and in print, it’s free under our creative commons attribution license, but please follow some simple guidelines:
  1. You have to credit our authors.
  2. You have to credit SciDev.Net — where possible include our logo with a link back to the original article.
  3. You can simply run the first few lines of the article and then add: “Read the full article on SciDev.Net” containing a link back to the original article.
  4. If you want to also take images published in this story you will need to confirm with the original source if you're licensed to use them.
  5. The easiest way to get the article on your site is to embed the code below.
For more information view our media page and republishing guidelines.

The full article is available here as HTML.

Press Ctrl-C to copy

There are 14,000 new HIV infections every day, with over 95 per cent occurring in developing countries. The best way of controlling the spread of the virus would be to develop an effective vaccine against it.

However, HIV presents particularly difficult obstacles to the creation of a successful vaccine. Unlike other viruses, it is capable of thwarting both antibody and cellular immune responses to infection. In this article published in Science, Emilio Emini and Wayne Koff review the challenges of developing HIV vaccines and outline recent progress and best hopes for the future.

They conclude that what is needed most is a degree of collaboration that far surpasses current global efforts.

Link to full article in Science

Reference: Science 304, 1913 (2004)

Related topics